Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

83.89 -0.21 (-0.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried
The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval. 
Via Investor's Business Daily
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements. 
Via Chartmill
Dexcom Appoints Renée Galá to Board of Directors
From DexCom, Inc.
Via Business Wire
DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Based on technical and fundamental analysis of NASDAQ:DXCM we find: DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
3 Growth Stocks to Buy and Hold Forever
Via The Motley Fool
DexCom Analysts Increase Their Forecasts After Q4 Earnings
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
Should You Buy DexCom Stock Before Feb. 13?
Via The Motley Fool
Deep Dive Into DexCom Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom... 
Via StockStory
Topics Artificial Intelligence
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
These S&P500 stocks are moving in today's pre-market session
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Insulet Earnings: What To Look For From PODD
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect. 
Via StockStory
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
What's going on in today's session: S&P500 movers
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday. 
Via Chartmill
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. 
Via Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. 
Via Chartmill
Stocks Head For Weekly Gains, US Treasury Yields Fall Below 4.5%: What's Driving Markets Friday?
Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday. 
Via Benzinga
Topics Stocks
Discover which S&P500 stocks are making waves on Friday.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Dexcom Q4 Earnings: Expanding Sales, New Products, Margin Pressure And More
Dexcom reported Q4 results, with revenue up 8%, beating estimates. CEO looks forward to unlocking next wave of global access. 
Via Benzinga
DexCom (DXCM) Q4 2024 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
DexCom: Revenue Up, EPS Misses Mark
DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. 
Via The Motley Fool
DexCom’s (NASDAQ:DXCM) Q4: Beats On Revenue
Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 7.6% year on year to $1.11 billion. The company expects the full year’s... 
Via StockStory
Topics Artificial Intelligence
Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations
Dexcom stock fell late Thursday after the company missed fourth-quarter profit expectations by a nickel per share. 
Via Investor's Business Daily
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
From DexCom, Inc.
Via Business Wire
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Based on a technical and fundamental analysis of NASDAQ:DXCM we can say: DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.